HomepageEarnings Events Newsdesk 20 hours ago Huntington Ingalls Industries, Inc (HII) Q4 2025 Earnings Call Huntington Ingalls Industries, Inc (NYSE: HII) Q4 2025 Earnings Conference Johnson & Johnson (JNJ) FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month » « Vontier Corporation (VNT) Citi’s Global Industrial Tech and Mobility Conference Newsdesk: